New Releases from NCBI BookshelfSemaglutide (Wegovy): Indication: As an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of:: Reimbursement Recommendation [Internet].​Semaglutide (Wegovy): Indication: As an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of:: Reimbursement Recommendation [Internet].

Canada’s Drug Agency (CDA-AMC) recommends that Wegovy be reimbursed by public drug plans for chronic weight management if certain conditions are met.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top